The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

A significant number of Tuberculosis (TB) cases continue to go undetected due to the limited sensitivity of smear microscopy, the most commonly used diagnostic test for TB in India.

The World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for ...

On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...